Tumor necrosis in magnetic resonance imaging predicts urothelial carcinoma with squamous differentiation in muscle-invasive bladder carcinoma

被引:1
|
作者
Park, Jae Hyon [1 ]
Kim, Milim [2 ]
Yoon, Jongjin [3 ]
Park, Insun [4 ]
Jung, Dae Chul [3 ]
Kang, Byung-Chul [3 ]
Oh, Young Taik [3 ]
机构
[1] Armed Forces Daejeon Hosp, Dept Radiol, Daejeon, South Korea
[2] Yonsei Univ, Coll Med, Severance Hosp, Dept Pathol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Severance Hosp, Res Inst Radiol Sci,Dept Radiol, Seoul, South Korea
[4] Seoul Natl Univ, Dept Anesthesiol & Pain Med, Bundang Hosp, Seongnam, South Korea
关键词
Carcinoma; Transitional cell; Cystectomy; Histology; Magnetic resonance imaging; Pathology; Urinary bladder neoplasms; HISTOLOGICAL VARIANTS; RADICAL CYSTECTOMY; ONCOLOGIC OUTCOMES; CELL-CARCINOMA; IMPACT; CANCER;
D O I
10.1007/s00261-024-04317-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose This study investigated radiologic features on preoperative MRI to differentiate urothelial carcinoma with squamous differentiation (UCSD) from conventional urothelial carcinoma (UC) in muscle-invasive bladder carcinoma. Methods Ninety-nine patients who underwent radical cystectomy and a preoperative bladder MRI scan within three months before surgery were retrospectively enrolled. Various MRI features, including tumor length, location, multiplicity, long-to-short axis ratio, morphology, radiologic stage, and degree of severe necrosis, were analyzed. Univariable and multivariable logistic regression analyses were performed to identify MRI features predictive of UCSD. The diagnostic performance of a significant MRI feature was assessed using 5-fold cross-validation. Results Among the MRI features, significant radiologic findings associated with UCSD in the univariable analysis included heterogeneous tumor signal intensity in T2-weighted images (odds ratio [OR], 3.365; 95% confidence interval [CI], 1.213-9.986; P = 0.022) and contrast-enhanced T1-weighted images (OR, 4.428; 95% CI, 1.519-12.730; P = 0.007), as well as marked (>= 50%) severe necrosis (OR, 17.100; 95% CI, 4.699-73.563; P < 0.001). In the multivariable analysis, marked (>= 50%) severe necrosis (odds ratio [OR], 13.755; 95% confidence interval [CI], 2.796-89.118; P = 0.004) was a significant predictor of UCSD. Marked (>= 50%) severe necrosis showed a high specificity of 95.0% with a precision of 65.0% for diagnosing UCSD based on 5-fold cross-validation. Conclusion Preoperative bladder MRI revealing marked severe necrosis may be indicative of UCSD and can assist in distinguishing it from conventional UC.
引用
收藏
页码:4341 / 4351
页数:11
相关论文
共 50 条
  • [1] Adjuvant immunotherapy for muscle-invasive urothelial carcinoma of the bladder
    Alevizakos, Michail
    Bellmunt, Joaquim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (03) : 259 - 267
  • [2] Multimodal therapies for muscle-invasive urothelial carcinoma of the bladder
    Keegan, Kirk A.
    Resnick, Matthew J.
    Clark, Peter E.
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (03) : 278 - 283
  • [3] Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder
    Hensley, Patrick J.
    Goodwin, Jeffrey
    Davenport, Daniel L.
    Strup, Stephen E.
    James, Andrew
    CLINICAL GENITOURINARY CANCER, 2018, 16 (04) : E851 - E858
  • [4] Nonresponse to Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Cell Carcinoma of the Bladder
    Mossanen, Matthew
    Lee, Franklin
    Cheng, Heather
    Harris, William
    Shenoi, Jaideep
    Zhao, Song
    Wang, Junfeng
    Champion, Thomas
    Izard, Jason
    Gore, John L.
    Porter, Michael P.
    Yu, Evan Y.
    Wright, Jonathan L.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (03) : 210 - 213
  • [5] Imaging muscle-invasive and metastatic urothelial carcinoma
    Malayeri, Ashkan A.
    Pattanayak, Puskar
    Apolo, Andrea B.
    CURRENT OPINION IN UROLOGY, 2015, 25 (05) : 441 - 448
  • [6] Surgical management of bladder urothelial carcinoma with squamous differentiation
    Raman, Jay D.
    Jafri, Syed M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (10) : 429 - 433
  • [7] Lymphadenectomy for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma
    Sathianathen, Niranjan J.
    Risk, Michael C.
    Konety, Badrinath R.
    UROLOGIC CLINICS OF NORTH AMERICA, 2018, 45 (02) : 215 - +
  • [8] Lack of Pathologic Down-Staging With Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder
    Weight, Christopher J.
    Garcia, Jorge A.
    Hansel, Donna E.
    Fergany, Amr F.
    Campbell, Steven C.
    Gong, Michael C.
    Jones, J. Stephen
    Klein, Eric A.
    Dreicer, Robert
    Stephenson, Andrew J.
    CANCER, 2009, 115 (04) : 792 - 799
  • [9] Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
    Kim, Hongsik
    Jeong, Byong Chang
    Hong, Joohyun
    Kwon, Ghee Young
    Kim, Chan Kyo
    Park, Won
    Pyo, Hongryull
    Song, Wan
    Sung, Hyun Hwan
    Hong, Jung Yong
    Park, Se Hoon
    CANCER RESEARCH AND TREATMENT, 2023, 55 (02): : 636 - 642
  • [10] Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder
    Supit, Wempy
    Mochtar, Chaidir Arif
    Santoso, Rachmat Budi
    Umbas, Rainy
    ASIAN JOURNAL OF SURGERY, 2014, 37 (04) : 184 - 189